Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 9, 2007
- Accepted June 19, 2007
- Published online August 27, 2007.
Article Versions
- Earlier version (August 16, 2007 - 07:51).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2007 by the American Society of Nephrology
Author Information
- *Clinical Research Centre for Rare Diseases “Aldo e Cele Daccò,” Mario Negri Institute for Pharmacological Research, Villa Camozzi, Ranica, and †Unit of Nephrology, Azienda Ospedaliera Ospedali Riuniti, Bergamo, Italy
- Address correspondence to:
Dr. Piero Ruggenenti, “Mario Negri” Institute for Pharmacological Research, Negri Bergamo Laboratories, Via Gavazzeni, 11-24125 Bergamo, Italy. Phone: +39-035-319-888; Fax: +39-035-319-331; E-mail: manuelap{at}marionegri.it
Statistics from Altmetric.com
Article usage
Cited By...
In this issue
Titrating Rituximab to Circulating B Cells to Optimize Lymphocytolytic Therapy in Idiopathic Membranous Nephropathy
Jump to section
More in this TOC Section
Cited By...
- Clinical Response and Pattern of B cell Suppression with Single Low Dose Rituximab in Nephrology
- Ofatumumab for multirelapsing membranous nephropathy complicated by rituximab-induced serum-sickness
- High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy
- Safety of Rituximab Compared with Steroids and Cyclophosphamide for Idiopathic Membranous Nephropathy
- Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up
- MANAGEMENT OF ENDOCRINE DISEASE: Rituximab therapy for Graves orbitopathy - lessons from randomized control trials
- Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy
- Refractory focal segmental glomerulosclerosis in the adult: complete and sustained remissions of two episodes of nephrotic syndrome after a single dose of rituximab
- Rituximab in Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome
- Treatment of Idiopathic Membranous Nephropathy
- Rituximab in Idiopathic Membranous Nephropathy
- Rituximab Therapy in Idiopathic Membranous Nephropathy: A 2-Year Study
- Successful Treatment of Membranous Glomerulonephritis with Rituximab in Calcineurin Inhibitor-Dependent Patients
- Overcoming Calcineurin Dependence in Membranous Nephropathy: Is Rituximab the Answer?
- Rituximab Therapy for Membranous Nephropathy: A Systematic Review
- Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008